Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.
Also called NCT03807037
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 250 participants
- Sponsor
- Monash University Malaysia
- Registry
-
NCT03807037
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Malaysia
- Registry status
- Completed
Technical summary
Registry record NCT03807037. Randomized; triple masking; primary purpose prevention. Start 2018-12-17 (actual); primary completion 2021-12-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Intervention (Dietary supplement)
- Tocotrienols
- Intervention (Drug)
- Placebo oral capsule
- Lead sponsor
- Monash University Malaysia
- Collaborator
- Institut Jantung Negara
Record details
- Record id
cardio:ct-nct03807037- Content hash
43bcdc9864f77bb0fe2b8b3ea620e9507808dd3eceac2b6bd89709568b3e118c